Large pharma teams like Novo Nordisk are much better outfitted to handle a feasible United States toll than tiny and medium-sized firms, states primary financial expert at Danish single-interest group.
发布者:BY MARIA OUTZE NIELSEN,转转请注明出处:https://robotalks.cn/chief-economist-not-all-pharma-companies-will-be-hit-equally-hard-by-trumps-tariffs/